-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$24.20101.33% Upside
Replimune Group, Inc. Frequently Asked Questions
-
What analysts cover Replimune Group, Inc.?
Replimune Group, Inc. has been rated by research analysts at H.C. Wainwright, Barclays, BMO Capital, Leerink Partners, Piper Sandler in the past 90 days.